Study Information
Protocol Title
A retrospective chart review study of cefiderocol real world outcomes and safety in the treatment of patients with Gram-negative bacterial infections (GNBI) in the US and Europe
Short Title
PROVE (Retrospective Cefiderocol Chart Review Study)
Study Phase/Type of Study
Phase1
Shionogi Product Code
000001
Status
Active
Country / Site list
Country Name Site Number Site Name PI Name Current Status
UK 001 Name Name Active
Spain 002 Name Name Active
Germany 003 Name Name Active
Germany 004 Name Name Active
Study Personnel
Full name Affiliation Function Start date End date Email address Phone number Site/country responsibility
Firstname Lastname Shionogi Market Access DD/MM/YYYY DD/MM/YYYY firstname.lastname@emailaddress.com +44 1234 567890 All
Firstname Lastname CRO/vendor Regulatory DD/MM/YYYY DD/MM/YYYY firstname.lastname@emailaddress.com +44 1234 567890 Germany